AI Summary

NIH researchers have identified rare antibodies that may guide the creation of a treatment for alpha‑gal syndrome, a tick‑bite‑linked allergy to a red‑meat molecule. Laboratory experiments showed the antibodies functioned as a biological shield, preventing human allergic antibodies from attaching to the meat allergens. The results were reported in the Journal of Clinical Investigation.

AI summaries can be wrong sometimes—always verify important details using the source article.